BVF Partners L P/il, 10% Owner at INFINITY PHARMACEUTICALS, INC. (INFI), bought 5,967,422 shares at $1.65 ($9.8M) on 2018-06-21, disclosed to the SEC on 2018-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 179,893 | $297K | 3.0% |
| 2 | $1.65 | 179,893 | $297K | 3.0% |
| 3 | $1.65 | 1,419,907 | $2.3M | 23.8% |
| 4 | $1.65 | 1,419,907 | $2.3M | 23.8% |
| 5 | $1.65 | 1,916,760 | $3.2M | 32.1% |
| 6 | $1.65 | 36,825 |
| $61K |
| 0.6% |
| 7 | $1.65 | 36,825 | $61K | 0.6% |
| 8 | $1.65 | 158,151 | $261K | 2.7% |
| 9 | $1.65 | 158,151 | $261K | 2.7% |
| 10 | $1.65 | 230,555 | $380K | 3.9% |
| 11 | $1.65 | 230,555 | $380K | 3.9% |
| Total | $1.65 avg | 5,967,422 | $9.8M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |